About the founder/CEO

Malini Chatterjee is the CEO of Bio Intuition, a healthcare (therapeutics) consulting company she founded in 2008.  Bio Intuition provides situation-analysis on many critical issues that sponsors, investors and doctors face during drug development. These include analysis and recommendations on moleular structure and biology of a given drug, clinical trial design and statistics, marketplace size/dynamics/analytics, marketing messages, medical conference assistants, analysis of IMS/NDC prescription, patent analysis, IPO design and investor message testing, biotech image makeover (crisis analysis) and M&A strategy analysis.

Prior to founding Bio Intuition, between 2004-2008, Malini worked as head of heathcare research, portfolio manager and biotech analyst at Kamunting Street Capital and SAC Capital, two large NYC based hedge-fund, where she was responsible for over $500MM of biotech exposure.

Previous to entering Wall St, Malini was a medical director at HealthSciences Communications, a healthcare consulting company, she was spearheaded clinical trial development and commercial landscape analysis projects for her key clients, Genentech (Avastin and Tarceva), Sanofi (Oxaliplatin) and Millenium Pharmaceuticals (Velcade).

Malini secured her PhD in molecular oncology (magna cum laude) from Columbia University,New York, and her MSc and BSc in microbiology and math from University of Bombay, India.

New York, NY